$LUNG SEC Filings

Filed On	Filing
27 Oct 2026	8-K: Results of Operations and Financial Condition (Former name or former address, if changed since last report.)
03 Sep 2026	Form 4: French Glendon E. Iii, Director Sold 41,882 shares ($94.7K)
03 Sep 2026	Form 4: Radhakrishnan Srikanth, Chief Science & Techn. Officer Sold 14,245 shares ($32.2K)
03 Sep 2026	Form 4: Lehman David Aaron, General Counsel Sold 14,334 shares ($32.4K)
03 Sep 2026	Form 4: Rose Geoffrey Beran, Chief Commercial Officer Sold 7,879 shares ($17.8K)
13 Aug 2026	SCHEDULE 13G/A
04 Aug 2026	10-Q
29 Jul 2026	SCHEDULE 13G/A
29 Jul 2026	8-K: Results of Operations and Financial Condition
09 Jun 2026	Form 4: Burns Thomas William, Director Received 40,000 shares as a grant or award
09 Jun 2026	Form 4: Ferrari Richard, Director Received 40,000 shares as a grant or award
09 Jun 2026	Form 4: Florin Daniel P, Director Received 40,000 shares as a grant or award
09 Jun 2026	Form 4: Melenikiotou Georgia, Director Received 40,000 shares as a grant or award
09 Jun 2026	Form 4: Sullivan Tiffany, Director Received 40,000 shares as a grant or award
09 Jun 2026	Form 4: Mead Dana G Jr., Director Received 40,000 shares as a grant or award
04 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
03 Jun 2026	Form 4: Radhakrishnan Srikanth, Chief Science &Techn. Officer Sold 14,497 shares ($22.3K)
03 Jun 2026	Form 4: Lehman David Aaron, GENERAL COUNSEL Sold 14,594 shares ($22.5K)
03 Jun 2026	Form 4: Rose Geoffrey Beran, CHIEF COMMERCIAL OFFICER Sold 8,023 shares ($12.4K)
03 Jun 2026	Form 4: French Glendon E. Iii, Director Sold 42,638 shares ($65.7K) · Sold 13,511 shares ($21.2K)

Comments